Smoking Cessation App. in Arabic

ConditionSmoking Cessation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorYarmouk University

About this trial

Smoking remains a significant global health challenge, causing over 8 million deaths annually, with the burden predominantly in low- and middle-income countries. Jordan experiences some of the highest smoking rates worldwide, contributing to substantial health risks and premature mortality. Despite the prevalence of mobile health (mHealth) applications for smoking cessation, few have supported the Arabic language and none have been evaluated for their efficacy. Our main goal is to develop a culture-sensitive mHealth app in Arabic for smoking cessation and test its efficacy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Study participants will be students attending Yarmouk University recruited through emails and flyers distributed to all offer the University's Faculties. Participation will be on a voluntary base. Only students who fulfill the following criteria will be invited to participate in the study. The inclusion criteria are: 1) a Yarmouk University student, 2) aged 18 years old and above, 3) smoked ≥5 cigarettes a day for the past year (25), 4) have a smartphone (iOS or Android), and 4) express willingness to quit smoking.

Disqualifiers

The exclusion criteria are: 1) non-Arabic speaker, 2) have certain conditions that interfere with the intervention like blindness or deafness, 3) have clinical depression or mental illness, 4) smoke only hookah, or 5) participate in another smoking cessation program.

Trial design

Design model

Parallel

Treatments tested in this trial

iEndSmokin App
Behavioral
Mobile Health App that includes educational material and psychological programs based on CBT.
Educational Session
Behavioral
It will include lectures and distribution of educational material about smoking health risks and strategies to quit.

Treatment groups

150 Participants

are divided into 2 treatment groups

Group A: App GroupExperimental treatment 1 intervention

Group B: Education GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

Successful quit attempt

A successful smoking quit event is defined as follows: Participants reported 30 days' abstinence from smoking and all nicotine/tobacco products (Hookah, e-cigarettes, HEETS, cigars, gums …etc.), and very low level of nicotine level (account for second-hand smoking levels) will be considered translated into 30-point abstinence prevalence, and the normal nicotine level in saliva or blood level. Smoking status was the self-reported response to the question "When was the last time you smoked or even tried a cigarette?" Responses choices were "Earlier today", "24 hours ago", "2-7 days ago", "8-30 days ago", and "Over 30 days ago". Salivary or blood Cotinine level test is sensitive to nicotine level for 48-72 hrs. and the samples can be stored for up to three months without jeopardizing the validity of the test

Time frame

3 months

Secondary outcomes

Reduction in Smoking Rate

7-day point prevalence abstinence outcome or decrease in daily cigarettes use

Time frame

3 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yarmouk University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: